Swiss National Bank purchased a new position in shares of MeiraGTx Holdings PLC (NASDAQ:MGTX) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 24,800 shares of the company’s stock, valued at approximately $667,000. Swiss National Bank owned 0.07% of MeiraGTx at the end of the most recent quarter.
A number of other institutional investors have also made changes to their positions in MGTX. CIBC Private Wealth Group LLC bought a new position in shares of MeiraGTx during the second quarter worth about $516,000. Ibex Investors LLC acquired a new position in shares of MeiraGTx during the second quarter valued at approximately $278,000. Financial Advisory Service Inc. bought a new stake in MeiraGTx during the second quarter worth approximately $230,000. Strs Ohio lifted its position in MeiraGTx by 138.4% in the 2nd quarter. Strs Ohio now owns 26,700 shares of the company’s stock worth $717,000 after buying an additional 15,500 shares in the last quarter. Finally, Focused Wealth Management Inc purchased a new stake in MeiraGTx in the 2nd quarter worth approximately $57,000. 37.41% of the stock is owned by hedge funds and other institutional investors.
In related news, Director Life Sciences Maste Perceptive acquired 425,531 shares of the stock in a transaction dated Monday, August 12th. The stock was bought at an average price of $23.50 per share, for a total transaction of $9,999,978.50. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 17.40% of the company’s stock.
Shares of MeiraGTx stock traded down $0.29 during trading on Friday, hitting $19.35. 596 shares of the company’s stock traded hands, compared to its average volume of 132,855. The company has a debt-to-equity ratio of 0.12, a current ratio of 5.22 and a quick ratio of 5.22. The firm’s fifty day moving average price is $22.80 and its 200 day moving average price is $21.59. MeiraGTx Holdings PLC has a twelve month low of $8.53 and a twelve month high of $30.23. The company has a market cap of $652.04 million, a PE ratio of -4.41 and a beta of 2.19.
MeiraGTx (NASDAQ:MGTX) last issued its earnings results on Wednesday, August 7th. The company reported ($0.63) earnings per share for the quarter, missing the consensus estimate of ($0.16) by ($0.47). The firm had revenue of $1.98 million for the quarter. As a group, equities research analysts anticipate that MeiraGTx Holdings PLC will post -2.75 earnings per share for the current year.
Several analysts have issued reports on MGTX shares. Piper Jaffray Companies started coverage on shares of MeiraGTx in a research report on Tuesday, September 3rd. They issued an “overweight” rating and a $40.00 price target on the stock. ValuEngine lowered shares of MeiraGTx from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Finally, Zacks Investment Research lowered shares of MeiraGTx from a “buy” rating to a “sell” rating in a research report on Wednesday, May 29th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $32.50.
MeiraGTx Holdings plc, a clinical-stage gene therapy company, focusing on developing treatments for patients living with serious diseases. The company develops various therapies for ocular diseases, including rare inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; neurodegenerative diseases, such as amyothrophic lateral sclerosis; and Parkinson's diseases.
Read More: Cash Asset Ratio
Want to see what other hedge funds are holding MGTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MeiraGTx Holdings PLC (NASDAQ:MGTX).
Receive News & Ratings for MeiraGTx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MeiraGTx and related companies with MarketBeat.com's FREE daily email newsletter.